Information Provided By: 
Fly News Breaks for February 28, 2019
WCG
Feb 28, 2019 | 08:52 EDT
Cowen analyst Charles Rhyee initiated WellCare with an Outperform rating. The analyst noted the shares trade at a premium, which he believes is justified given visibility into multi-year growth drivers such including Meridian, organic wins such as North Carolina, the addition of Aetna's prescription drug lives in 2020, and PBM re-contracting for 2021. Ryhee has a $335 price target on WellCare shares.
News For WCG From the Last 2 Days
There are no results for your query WCG
